Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate
NCT ID: NCT05779735
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
182 participants
INTERVENTIONAL
2023-09-13
2025-10-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this new study is therefore to validate the results of this PILOT study in a more powerful multicenter randomized trial (DELIVERY).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Interests of Mesure of Ultrasound " Angle of Progression " on the Cesarean Rate :a Randomized Comparative Prospective Study Multicenter Center Open
NCT02761304
Intrapartum Ultrasound for Assessment of Fetal Progression
NCT05718180
The Role of Ultrasonography in Labor in Predicting the Outcomes of Childbirth
NCT06806904
Prediction of Delivery Mode by Ultrasound-assessed Fetal Position in Nulliparous Women With Prolonged First Stage of Labor.
NCT05206409
Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time
NCT02570620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 : control
The mode of delivery will be determined by clinical examens (digital examination)
No interventions assigned to this group
Group 2 : Transperineal ultrasound measurements of AOP
The mode of delivery will be determined by clinical examens (digital examination) and ultrasound measurement of the AOP :
* vaginal delivery is encouraged if AOP measurement is \>120°
* cesarean delivery is encouraged if AOP measurement is \<= 120°
Transperineal ultrasound measurements of AOP
The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transperineal ultrasound measurements of AOP
The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> or = 37 weeks amenorrhoea
* Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound
* uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours),
Exclusion Criteria
* Presentation other than cephalic,
* Twin pregnancies,
* Posterior or transverse position
* Transperineal ultrasound for head-perineum distance measurement
* Fetal heart rate abnormalities requiring rapid delivery,
* Contraindication to vaginal delivery whether maternal or fetal
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital St. Joseph, Marseille, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Baptiste Haumonte
Role: PRINCIPAL_INVESTIGATOR
Hopital Saint Joseph Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Lille - Hôpital Jeanne de Flandre
Lille, , France
APHM Hôpital Conception
Marseille, , France
Hopital Saint Joseph
Marseille, , France
APHM Hôpital Nord
Marseille, , France
Hôpital Armand Trousseau AP-HP
Paris, , France
CHIC Poissy
Poissy, , France
CHITS Hôpital Sainte Musse
Toulon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rahamia AHAMADA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01978-35 DELIVERY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.